Title:
PDE4B INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/232135
Kind Code:
A1
Abstract:
Disclosed are a compound as represented by formula I; a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing same; and the use thereof as a PDE4B inhibitor in the preparation of a drug for the treatment of related diseases. Each group as shown in formula (I) is as defined in the description.
Inventors:
LI YAO (CN)
CHEN LEI (CN)
SHI ZONGJUN (CN)
REN LEI (CN)
HUANG SHUAI (CN)
YANG SHUANG (CN)
HE TIANCHENG (CN)
WANG JIE (CN)
CHENG FENGKAI (CN)
ZHANG CHEN (CN)
YAN PANGKE (CN)
CHEN LEI (CN)
SHI ZONGJUN (CN)
REN LEI (CN)
HUANG SHUAI (CN)
YANG SHUANG (CN)
HE TIANCHENG (CN)
WANG JIE (CN)
CHENG FENGKAI (CN)
ZHANG CHEN (CN)
YAN PANGKE (CN)
Application Number:
PCT/CN2023/097944
Publication Date:
December 07, 2023
Filing Date:
June 02, 2023
Export Citation:
Assignee:
TIBET HAISCO PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D495/04; A61K31/519; A61P11/00; C07D519/00
Domestic Patent References:
| WO2014124860A1 | 2014-08-21 |
Foreign References:
| CN101827853A | 2010-09-08 | |||
| US20110046096A1 | 2011-02-24 | |||
| CN101827852A | 2010-09-08 | |||
| US20130225609A1 | 2013-08-29 | |||
| CN111278442A | 2020-06-12 | |||
| CN103889970A | 2014-06-25 | |||
| CN111712502A | 2020-09-25 |
Attorney, Agent or Firm:
BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: